TY PHAR.(SZ:002728) Xin Lang Cai Jing·2025-10-20 05:32Core Viewpoint - On October 20, Te Yi Pharmaceutical experienced a 5.3% increase in stock price, reaching 9.34 CNY per share, with a trading volume of 145 million CNY and a turnover rate of 4.26%, resulting in a total market capitalization of 4.788 billion CNY [1] Company Overview - Te Yi Pharmaceutical Group Co., Ltd. is located in Taicheng, Guangdong Province, and was established on May 23, 2002, with its listing date on July 31, 2014 [1] - The company's main business involves the research, development, production, and sales of traditional Chinese medicine, chemical preparations, and chemical raw materials [1] - The revenue composition of the company is as follows: Traditional Chinese medicine 61.00%, chemical preparations 32.61%, chemical raw materials 5.77%, and chemical products and others 0.61% [1] Fund Holdings - According to data from the top ten heavy stocks of funds, one fund under GF Fund holds a significant position in Te Yi Pharmaceutical [2] - GF Xinhe Mixed A (004750) held 246,200 shares in the second quarter, accounting for 0.21% of the fund's net value, ranking as the tenth largest heavy stock [2] - The estimated floating profit for today is approximately 115,700 CNY [2] - GF Xinhe Mixed A was established on January 16, 2018, with a latest scale of 171 million CNY, and has achieved a year-to-date return of 3.42% [2] - The fund manager, Wu Di, has a tenure of 5 years and 168 days, with a total asset scale of 77.42 billion CNY [2]